January 18, 2023

Agreement Enables Innovative Scleral Lens Technology to Scale Up,
Includes 360-Degree Customer Support

SAN RAMON, CALIF., January 18, 2023—Keeping with its longstanding commitment to provide eye care practitioners (ECPs) with the most robust portfolio of specialty contact lens products and services, CooperVision Specialty EyeCare has become the exclusive provider of a pioneering scleral lens design system. Using a novel algorithm, ScanFitPRO software* precisely maps topographical data from patients’ eyes to create custom lens designs unique to their ocular profiles, without diagnostic lens fitting or physical impressions.

“We’re known for providing ECPs with inventive tools and resources they need to comfortably and confidently fit our lenses. The ScanFitPRO system enhances scleral design accuracy from the start, streamlining the fitting process,” said Dr. Juan Carlos Aragón, President, CooperVision Specialty EyeCare. “Our leading market presence offers the scale needed for SynergEyes ScanFitPRO to reach its potential. The addition of this technology to our portfolio will further strengthen our partnerships with the specialty eye care community, helping amplify their already significant impact on patients’ lives.”

Moving forward, all SynergEyes ScanFitPRO orders and customer support will be managed by CooperVision Specialty EyeCare. The technology was developed by EyePrint Prosthetics, which continues to operate as an independent company.

The ScanFitPRO design software is compatible with Oculus Pentacam’s Corneal Scleral Profile (CSP) Report, Oculus AXL Wave, and the Eaglet Eye’s Surface Profiler (ESP). Both scanning technologies capture the patients’ eye in a straight-ahead gaze, maximizing lens accuracy.

CooperVision Specialty EyeCare develops, manufactures, and provides access to an unmatched portfolio of industry-leading soft custom and rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea management, and presbyopia management. Its steady voice, ongoing research and innovative products and services play a leading role in expanding eye care worldwide. The group’s brands include Blanchard, GP Specialists, Paragon, Procornea, Soflex, EnsEyes, No7 Contact Lenses, and SynergEyes.

For additional information about the company’s products, please visit CooperVisionSpecialtyEyeCare.com.

# # #

* Pending FDA Clearance

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of roughly 14,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com

Media Contact
Maggie O’Donoghue, Counselor, McDougall Communications
maggie@mcdougallpr.com or +1-585-434-2149